The Penn research team, led by principal investigator Dr. Rajan Jain aims to study how cardiac cells establish and maintain their identity over a lifetime.
The goal of the gift, donated by Wharton alum Marc Wolpow, is to create an incubator and accelerator for student ventures in health care.
This new form of treatment turns off a cancer-attracting function in human blood vessels, which disables the pathways through which the cancer cells travel.
The symposium featured presentations and research posters by CiPD faculty and trainees in the Center’s NIDCR T90/R90 Postdoctoral Training Program as well as invited speakers.
From June 19-20, PCI attended 2023 Tech Connect World Innovation Conference and Expo, an annual event that brings together the creators of breakthrough technologies with corporations.
Qishui (Tracy) Chen, Assistant Director of Licensing, Physical Sciences, and Engineering shared and discussed a wide range of available drug delivery technologies come out of Penn.
Engheta was granted this prestigious award, which is one of the world’s oldest science and technology awards, for his transformative innovations in engineering novel metamaterials.
The FDA first approved of chimeric antigen receptor (CAR) T cell therapy in 2017, and Penn Medicine has since been dedicated to finding further applications to the treatment.
Penn Dental Medicine and Penn Engineering Faculty Invent Nanorobotic system That Offers new options for targeting fungal infections
This research team has developed a new way to accurately target and quickly destroy fungal cells in the mouth by using nanorobots guided by magnets.
Penn Dental Medicine Researchers Develop Plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin
Henry Daniell and his team of researchers developed a new plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin.